KLI

M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib

Metadata Downloads
Publisher
Pharmacological Reports
Language
영어
ISSN
1734-1140
Citation Volume
73
Citation Start Page
185
Citation End Page
201
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.